ARTACIL 2.5ML

ARTACIL 2.5ML

Key Features:

· Accurate low-dose presentation

· Reliable neuromuscular blocking effect

· Suitable for hospital and institutional supply

· Manufactured under strict GMP quality standards

Note: To be administered only by qualified anesthesiologists or trained healthcare professionals in appropriate clinical settings.

Brand Name: ARTACIL 25mg/2.5ml
Generic Name: Atracurium Besylate Injection I.P.
Strength: 25 mg / 2.5 ml
Dosage Form: Injection
Manufacturer: Neon Laboratories Limited
Packaging: Standard company packing

Product Description:

ARTACIL 25mg/2.5ml Injection contains Atracurium Besylate, a non-depolarizing neuromuscular blocking agent used as an adjunct to general anesthesia. It is primarily indicated for facilitating endotracheal intubation and providing controlled skeletal muscle relaxation during surgical procedures and mechanical ventilation.

This formulation is suitable for precise dosing requirements in operation theatres and intensive care units. Atracurium Besylate provides predictable and intermediate-duration neuromuscular blockade under proper medical supervision.

Common Uses:

· Facilitation of endotracheal intubation

· Muscle relaxation during surgical procedures

· ICU ventilation management

· Adjunct to general anesthesia